AXSOME THERAPEUTICS INC. - COMMON STOCK
121.91
14-March-25 16:45:00
15 minutes delayed
Stocks
+0.26
+0.21%
Today's range
120.52 - 123.47
ISIN
N/A
Source
NASDAQ
-
Axsome Therapeutics Recognizes May as Mental Health Awareness Month
01 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
10 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
01 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
25 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
25 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
19 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
05 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
20 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20
23 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
07 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7
22 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
21 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
24 Oct 2023 07:00:00 By Nasdaq GlobeNewswire